Loading…
The clearance allows for the marketing of the new medical device.
Tenon Medical, Inc. (Nasdaq: TNON) announced that it has received FDA 510(k) clearance for its Catamaran SI Joint Fusion System. This clearance permits the company to market the new device for sacroiliac joint fusion procedures.
The Catamaran SI Joint Fusion System is designed to provide stabilization and fusion of the sacroiliac joint, addressing conditions such as sacroiliac joint dysfunction.
As of the latest company context, Tenon Medical has a free float of 6,624,199 shares.
This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.